Recombinant Human IL-12 Protein
- FOB Price:Get Latest Price >
- Min.Order:1 Other(s)
- Payment Terms:T/T
- Favorite
Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
6/10
T&L Biotechnology
We are professional supplier of Recombinant human IL-7 protein,Recombinant Human IL-15 Protein,Recombinant Human IL-21 Protein,Humanized Anti-Human CD3 mAb,Humanized Anti-Human CD16 mAb,Humanized Anti
Business Type:Others
Country/Region:China
Ddu Verified
HOT Rank
6/10
Catalog Number: GMP-TL508
Product Name | |
Generic Name | Recombinant Human IL-12 Protein |
Synonym | IL12, p70, Interleukin-12 |
Product Information | |
Protein sequence | Recombinant human IL-12 is heterodimeric and composed of P29459-1 (IL12A) and P29460-1 (IL12B). |
Expression Host | HEK293 cells |
QC Testing Purity | > 90 % as determined by SDS-PAGE |
Activity | Determined by the dose-dependent secretion of interferon γ by human naturally killer lymphoma NK-92 cells.The expected ED 50 for this effect is ≤ 2 ng/ml. |
Endotoxin Level | < 0.1EU per 1 μg of the protein by the LAL method. |
Molecular Mass | The Recombinant Human IL-12 Protein predicts a molecular mass of 65 kDa. |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 6 % mannitol are added as protectants before lyophilization. |
Stability & Storage | 24 months at 2℃ to 8℃ in lyophilized state. 6 months at -20℃ under sterile conditions after reconstitution. 12 months at -80℃ under sterile conditions after reconstitution. Recommend to aliquot the protein into smaller quantities after reconstituting with water for injection, normal saline or PBS, and keep the diluted concentration above 100μg/mL. Avoid repeated freeze-thaw cycles. |
Background | |
IL-12 is primarily produced by monocytes, macrophages, B cells and DCs. IL-12 is a heterodimeric cytokine encoded by two separate genes, IL-12A (p35) and IL-12B (p40).IL-12 receptors are located mainly on T cells and NK cells, and IL-12 can stimulate Th1 and NK cell growth, while inhibiting Th2 cell responses. IL-12 augments cytotoxicity of T lymphocytes and NK cells through the enhancement of IFN-γ and TNF-α secretion, and inhibition of IL-4 production. | |
References | |
1. Frazão JB, Colombo M, Simillion C, Bilican A, Keller I, Wüthrich D, Zhu Z, Okoniewski MJ, Bruggmann R, Condino-Neto A, Newburger(2019)Gene expression in chronic granulomatous disease and interferon-γ receptor-deficient cells treated in vitro with interferon-γ. J Cell Biochem.120(3):4321-4332. Trial dosage: A customer can apply for up to five samples a year (the actual trial dosage is determined by telephone or email communication). |